Stay updated on Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAn updated revision label, v3.3.2, was added and the previous v3.2.0 label was removed.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding status notice on the page has been removed.SummaryDifference0.4%

- Check42 days agoChange DetectedDifference0.8%

- Check71 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference5%

- Check78 days agoChange DetectedPage updates: added a new code (972-3-9378002) and updated revision from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.